EE200300207A - Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical Composition - Google Patents
Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical CompositionInfo
- Publication number
- EE200300207A EE200300207A EEP200300207A EEP200300207A EE200300207A EE 200300207 A EE200300207 A EE 200300207A EE P200300207 A EEP200300207 A EE P200300207A EE P200300207 A EEP200300207 A EE P200300207A EE 200300207 A EE200300207 A EE 200300207A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- methods
- pharmaceutical composition
- heterocyclylalkylpiperidine derivatives
- heterocyclylalkylpiperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0014738A FR2816618B1 (en) | 2000-11-15 | 2000-11-15 | HETEROCYCLYLALCOYL PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
PCT/FR2001/003559 WO2002040474A2 (en) | 2000-11-15 | 2001-11-14 | Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300207A true EE200300207A (en) | 2003-08-15 |
Family
ID=8856503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300207A EE200300207A (en) | 2000-11-15 | 2001-11-14 | Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical Composition |
Country Status (28)
Country | Link |
---|---|
EP (2) | EP1695964A1 (en) |
JP (1) | JP2004514661A (en) |
KR (1) | KR100849608B1 (en) |
CN (1) | CN1483031A (en) |
AR (1) | AR034006A1 (en) |
AT (1) | ATE337311T1 (en) |
AU (2) | AU2002218365B2 (en) |
BG (1) | BG107793A (en) |
BR (1) | BR0115312A (en) |
CA (1) | CA2429311A1 (en) |
CZ (1) | CZ20031316A3 (en) |
DE (1) | DE60122567T2 (en) |
DK (1) | DK1337529T3 (en) |
EA (1) | EA200300568A1 (en) |
EE (1) | EE200300207A (en) |
ES (1) | ES2271119T3 (en) |
FR (1) | FR2816618B1 (en) |
HR (1) | HRP20030379A2 (en) |
HU (1) | HUP0303758A3 (en) |
IL (1) | IL155841A0 (en) |
NO (2) | NO20032187L (en) |
PL (1) | PL363004A1 (en) |
PT (1) | PT1337529E (en) |
SK (1) | SK5822003A3 (en) |
TN (1) | TNSN01160A1 (en) |
WO (1) | WO2002040474A2 (en) |
YU (1) | YU46803A (en) |
ZA (1) | ZA200303794B (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ2003243A3 (en) | 2000-07-26 | 2003-09-17 | Smithkline Beecham P. L. C. | Aminopiperidine quinolines and their azaisosteric analogs exhibiting antibacterial activity |
GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
WO2003064431A2 (en) | 2002-01-29 | 2003-08-07 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
JP4445753B2 (en) | 2002-01-29 | 2010-04-07 | グラクソ グループ リミテッド | Aminopiperidine derivatives |
TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
AR040336A1 (en) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | PIPERIDINE COMPOUND, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE SUCH COMPOUND |
FR2842807A1 (en) * | 2002-07-23 | 2004-01-30 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, PROCESS AND PREPARATION INTERMEDIATES AND COMPOSITIONS COMPRISING THE SAME |
GB0217294D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
FR2844268B1 (en) * | 2002-09-11 | 2004-10-22 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, PROCESSES AND INTERMEDIATES FOR THEIR PREPARATION, AND COMPOSITIONS CONTAINING THEM |
FR2844270B1 (en) | 2002-09-11 | 2006-05-19 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PROCESS AND PREPARATION INTERMEDIATES AND THE COMPOSITIONS CONTAINING THEM |
DE10256405A1 (en) * | 2002-12-02 | 2004-06-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
US7232832B2 (en) | 2002-11-05 | 2007-06-19 | Smithkline Beecham Corporation | Antibacterial agents |
AU2003294565A1 (en) | 2002-12-04 | 2004-06-23 | Glaxo Group Limited | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
FR2852954B1 (en) * | 2003-03-28 | 2006-07-14 | Aventis Pharma Sa | QUINOLINE-4-SUBSTITUTED DERIVATIVES, METHODS AND PREPARATION INTERMEDIATES THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US7232833B2 (en) | 2003-03-28 | 2007-06-19 | Novexel | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
FR2862301B1 (en) * | 2003-11-17 | 2007-12-21 | Aventis Pharma Sa | NEW PROCESS FOR THE PREPARATION OF 3-FLUORINATED QUINOLINES |
FR2867472B1 (en) * | 2004-03-12 | 2008-07-18 | Aventis Pharma Sa | QUINOLINE-4-SUBSTITUTED DERIVATIVES, METHODS AND PREPARATION INTERMEDIATES THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
EP1846416A4 (en) | 2005-01-25 | 2009-07-01 | Glaxo Group Ltd | Antibacterial agents |
US7605169B2 (en) | 2005-01-25 | 2009-10-20 | Glaxo Group Limited | Antibacterial agents |
JP2008528587A (en) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | Antibacterial agent |
US7592334B2 (en) | 2005-01-25 | 2009-09-22 | Glaxo Group Limited | Antibacterial agents |
MX2007010572A (en) | 2005-03-01 | 2007-10-04 | Wyeth Corp | Cinnoline compounds and their use as liver x receptor modilators. |
MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
ES2376488T3 (en) | 2006-01-26 | 2012-03-14 | Actelion Pharmaceuticals Ltd. | TETRAHYDROPIRAN ANTIBIOTICS. |
US7709483B2 (en) | 2006-04-06 | 2010-05-04 | Glaxo Group Limited | Pyrrolo-quinoxalinone derivatives as antibacterials |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
BRPI0812942B1 (en) | 2007-06-15 | 2018-11-21 | Actelion Pharmaceuticals Ltd | 3-amino-6- (1-amino-ethyl) -tetrahydropyran derivative compound, pharmaceutical composition and use of said compound. |
EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
EP2352734A1 (en) | 2008-10-17 | 2011-08-10 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
US8318940B2 (en) | 2009-01-15 | 2012-11-27 | Glaxo Group Limited | Naphthyridin-2 (1 H)-one compounds useful as antibacterials |
CA2881935A1 (en) * | 2012-08-15 | 2014-02-20 | Glaxo Group Limited | Process for preparing a 1-(2-haolethyl)-4-piperidine carboxylate intermediate useful in the synthesis of umeclidinium bromide |
CR20170069A (en) | 2014-08-22 | 2017-04-28 | Glaxosmithkline Intelectual Property Dev Ltd | TRICYCLIC COMPOUNDS CONTAINING NITROGEN FOR THE TREATMENT OF INFECTION BY NEISSERIA GONORRHOEAE |
WO2016138988A1 (en) * | 2015-03-02 | 2016-09-09 | University Of Copenhagen | Piperazine inhibitors of bacterial gyrase and topoisomerase iv |
UY36851A (en) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7908031A (en) | 1979-11-01 | 1981-06-01 | Acf Chemiefarma Nv | NEW QUINOLINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A COMPOUND AND METHOD FOR PREPARING THESE COMPOUNDS. |
JPH0239546A (en) | 1988-07-29 | 1990-02-08 | Origin Electric Co Ltd | Manufacture of hybrid integrated circuit |
AU623474B2 (en) | 1989-01-16 | 1992-05-14 | Laboratoire Roger Bellon | New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them |
DE69908555T2 (en) * | 1998-01-26 | 2004-05-06 | Smithkline Beecham P.L.C., Brentford | CHINOLINE DERIVATIVES AS AN ANTIBACTERIAL MEDICINAL PRODUCT |
AU2437900A (en) * | 1999-01-20 | 2000-08-07 | Smithkline Beecham Plc | Piperidinylquinolines as protein tyrosine kinase inhibitors |
FR2852954B1 (en) * | 2003-03-28 | 2006-07-14 | Aventis Pharma Sa | QUINOLINE-4-SUBSTITUTED DERIVATIVES, METHODS AND PREPARATION INTERMEDIATES THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
2000
- 2000-11-15 FR FR0014738A patent/FR2816618B1/en not_active Expired - Fee Related
-
2001
- 2001-11-13 AR ARP010105289A patent/AR034006A1/en unknown
- 2001-11-14 WO PCT/FR2001/003559 patent/WO2002040474A2/en active IP Right Grant
- 2001-11-14 CA CA002429311A patent/CA2429311A1/en not_active Abandoned
- 2001-11-14 KR KR1020037006600A patent/KR100849608B1/en not_active IP Right Cessation
- 2001-11-14 PL PL01363004A patent/PL363004A1/en not_active Application Discontinuation
- 2001-11-14 CN CNA018210996A patent/CN1483031A/en active Pending
- 2001-11-14 PT PT01996538T patent/PT1337529E/en unknown
- 2001-11-14 EE EEP200300207A patent/EE200300207A/en unknown
- 2001-11-14 DK DK01996538T patent/DK1337529T3/en active
- 2001-11-14 SK SK582-2003A patent/SK5822003A3/en unknown
- 2001-11-14 TN TNTNSN01160A patent/TNSN01160A1/en unknown
- 2001-11-14 AT AT01996538T patent/ATE337311T1/en not_active IP Right Cessation
- 2001-11-14 CZ CZ20031316A patent/CZ20031316A3/en unknown
- 2001-11-14 JP JP2002543484A patent/JP2004514661A/en active Pending
- 2001-11-14 EA EA200300568A patent/EA200300568A1/en unknown
- 2001-11-14 BR BR0115312-9A patent/BR0115312A/en not_active Application Discontinuation
- 2001-11-14 ES ES01996538T patent/ES2271119T3/en not_active Expired - Lifetime
- 2001-11-14 AU AU2002218365A patent/AU2002218365B2/en not_active Ceased
- 2001-11-14 EP EP06010725A patent/EP1695964A1/en not_active Withdrawn
- 2001-11-14 HU HU0303758A patent/HUP0303758A3/en unknown
- 2001-11-14 EP EP01996538A patent/EP1337529B1/en not_active Expired - Lifetime
- 2001-11-14 AU AU1836502A patent/AU1836502A/en active Pending
- 2001-11-14 IL IL15584101A patent/IL155841A0/en unknown
- 2001-11-14 DE DE60122567T patent/DE60122567T2/en not_active Expired - Fee Related
- 2001-11-14 YU YU46803A patent/YU46803A/en unknown
-
2003
- 2003-05-09 BG BG107793A patent/BG107793A/en unknown
- 2003-05-13 HR HR20030379A patent/HRP20030379A2/en not_active Application Discontinuation
- 2003-05-14 NO NO20032187A patent/NO20032187L/en unknown
- 2003-05-15 ZA ZA200303794A patent/ZA200303794B/en unknown
-
2007
- 2007-04-25 NO NO20072142A patent/NO20072142L/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300207A (en) | Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical Composition | |
EE05104B1 (en) | Azetidine derivatives, methods for their preparation and pharmaceutical composition | |
EE05081B1 (en) | Pharmaceutical compositions containing 3-aminoacetidine derivatives, 3-aminoacetidine derivatives and methods for their preparation | |
EE04464B1 (en) | Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions | |
EE200300145A (en) | Aza and polyazanaphthalenylcarboxamides and pharmaceutical composition | |
EE200100431A (en) | 16-haloepothilone derivatives, process for their preparation and pharmaceutical use | |
EE04275B1 (en) | Quinoline derivatives, processes for their preparation, use and pharmaceutical compositions | |
EE200300237A (en) | Diphenyl azetidinone derivatives, their use, drug and method of its preparation | |
EE200300238A (en) | Diphenyl azetidinone derivatives, their use, drug and method of its preparation | |
EE200300327A (en) | Urea derivatives, processes for their preparation, use and pharmaceutical composition | |
EE05643B1 (en) | Xanthine derivatives, their preparation and use as medicaments | |
EE05387B1 (en) | Quinazoline Derivatives, Method of Preparation and Use | |
EE200100391A (en) | Peptidyl-heterocyclic ketones, their use and pharmaceutical composition | |
EE200300048A (en) | Benzimidazole derivatives, their preparation and therapeutic use | |
EE200100470A (en) | Pyridopyranoazepine derivatives, their preparation and therapeutic use | |
EE200200607A (en) | 2-acylindole derivatives and their use as antitumor drugs | |
EE200100653A (en) | Indolylpiperidine Compounds, Method of Preparation, Composition and Use thereof | |
EE05242B1 (en) | Polymorphic form of 5-chloro-3- (4-methanesulfonylphenyl) -6'-methyl [2,3 '] biperidine, process for its preparation, use and pharmaceutical composition | |
EE200300245A (en) | Benzothiophene derivatives, process for their preparation and use | |
NO20022021D0 (en) | Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, the preparation of the same and their use as anorexic drugs | |
EE200300293A (en) | Conjugates of macrolide compounds with anti-inflammatory compounds, methods for their preparation and use | |
EE05004B1 (en) | Aminothiazole derivatives, their preparation and pharmaceutical compositions containing them | |
BR0208566B1 (en) | Beta-Carboline Derivatives, Their Use, and Pharmaceutical Composition | |
EE04812B1 (en) | 2-Phenylpyran-4-one derivatives, process for their preparation and use, use of intermediates and pharmaceutical composition | |
EE200100544A (en) | 15-membered 8α-and 9α-lactams, their method of preparation and pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB1A | Change in the ownership or in the address of the owner |